URI
43
-2
RIG
49
-5
OMC
35
-4
ALLE
35
-2
DE
53
-3
SYY
48
-2
DIS
77
2
MSI
50
-8
TMO
54
-2
NOV
40
-3
PYPL
60
-2
AXP
67
-3
HES
58
-3
JNJ
33
-2
UPS
53
2
EW
55
14
WY
45
-3
CHD
32
-2
WU
32
2
ECL
62
5
URI
43
-2
RIG
49
-5
OMC
35
-4
ALLE
35
-2
DE
53
-3
SYY
48
-2
DIS
77
2
MSI
50
-8
TMO
54
-2
NOV
40
-3
PYPL
60
-2
AXP
67
-3
HES
58
-3
JNJ
33
-2
UPS
53
2
EW
55
14
WY
45
-3
CHD
32
-2
WU
32
2
ECL
62
5
Financhill
Back

Ligand Pharmaceuticals Vs. Revance Therapeutics Industry Stock Comparison

Buy
51

LGND
Ligand Pharmaceuticals

Last Price:
113.46
Seasonality Move:
11.95%
Sell
9

RVNC
Revance Therapeutics

Last Price:
3.09
Seasonality Move:
2.04%
Buy
51
Ligand Pharmaceuticals (LGND) is a Buy

Is Ligand Pharmaceuticals a Buy, Sell or Hold?

  • The current Ligand Pharmaceuticals [LGND] share price is $113.51. The Score for LGND is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
9
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.09. The Score for RVNC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LGND Stock Price Chart

What is Ligand Pharmaceuticals's stock price today?

  • The Ligand Pharmaceuticals share price today is $113.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGND is experiencing selling pressure, which indicates risk of future bearish movement.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.

LGND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.35 Buy
Relative Strength Index (14 RSI): 44.78 Sell
Chaikin Money Flow: -103087 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (114.72 - 124.08) Sell
Bollinger Bands (100): (100.12 - 115.88) Buy

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 32.86 Sell
Chaikin Money Flow: 4004349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.3 - 4.38) Sell
Bollinger Bands (100): (3.85 - 6.27) Sell

LGND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.76 Sell
20-day SMA: 118.38 Sell
50-day SMA: 113.22 Buy
200-day SMA: 94.18 Buy
8-day EMA: 118.77 Sell
20-day EMA: 118.5 Sell
50-day EMA: 114.17 Sell
200-day EMA: 97.83 Buy

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.5 Sell
20-day SMA: 3.73 Sell
50-day SMA: 4.63 Sell
200-day SMA: 4.47 Sell
8-day EMA: 3.36 Sell
20-day EMA: 3.77 Sell
50-day EMA: 4.37 Sell
200-day EMA: 5.72 Sell

Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.58 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.63 per share.

Ligand Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):